In contrast, a recent study on the Japanese NAFLD patients found that the proportions of PNPLA3 and KCNQ1 variants did not differ much among the NAFLD non-diabetic and NAFLD diabetic groups. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.